Bodal Chemicals Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹588Cr
- +30.4% YoY
- +20% QoQ
- Net profit
- ₹32Cr
- +128.6% YoY
- Margin
- 12%
- +2 pp YoY
- +7.5 pp QoQ
Guidance rank: #34 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
Based on Bodal Chemicals Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q4 FY26 consolidated revenue: Rs. 5,906.0 mn, a 30.3% YoY growth from Rs. 4,532.2 mn in Q4 FY25 (Page 10). Q4 FY26 EBITDA: Rs. 711.5 mn, up 43.4% YoY from Rs. 496.1 mn in Q4 FY25 (Consolidated).
From Bodal Chemicals Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4 FY26 consolidated revenue: Rs. 5,906.0 mn, a 30.3% YoY growth from Rs. 4,532.2 mn in Q4 FY25 (Page 10).
- Q4 FY26 standalone revenue from operations: Rs. 5,771.0 mn, a 29.4% YoY increase from Rs. 4,455.3 mn in Q4 FY25 (Page 11).
- Revenue by segments in Q4 FY26 YoY growth: Dye intermediates Rs. 1,936 mn (+21%), Dyestuffs Rs. 1,441 mn (+15%), Basic Chemicals Rs. 632 mn (+239%) (Page 5).
- Outlook: Gradual growth expected in Saykha Benzene downstream products with meaningful QoQ contributions anticipated; ongoing volume improvements expected to enhance revenue and margins (Page 5).
Profitability & Margins
See what Bodal Chemicals Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The presentation mentions a new greenfield expansion under the "Way Forward" section (Page 28), indicating plans for capacity ramp-up and ongoing internal efficiencies.
- The "Integrated Business Model" section (Page 25) highlights investment in well-equipped production facilities and continuous R&D.
- The "Next Level of Growth" slide (Page 27) implies growth initiatives but lacks explicit capex/project details.
- Overall, the presentation commits to capacity expansion and new projects.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Bodal Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Bodal Chemicals Ltd said on order book & pipeline — free account, 30 seconds.
Bodal Chemicals Ltd — Quarterly revenue & net profit
Bodal Chemicals Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 588 | 451 | +30.4% | 490 | +20% |
| Operating profit (EBITDA) | 69 | 47 | +46.8% | 22 | +213.6% |
| Operating margin | 12% | 10% | +2 pp | 4.5% | +7.5 pp |
| Profit before tax | 36 | 12 | +200% | 0 | — |
| Net profit (PAT) | 32 | 14 | +128.6% | 0 | — |
| EPS (₹) | 2.55 | 1.15 | +121.7% | 0.02 | +12650% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹863 Cr, net profit ₹81 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Bodal Chemicals's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Bodal Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Bodal Chemicals Ltd Q4 FY26 results?
Q4 FY26 consolidated revenue: Rs. 5,906.0 mn, a 30.3% YoY growth from Rs. 4,532.2 mn in Q4 FY25 (Page 10). Q4 FY26 EBITDA: Rs. 711.5 mn, up 43.4% YoY from Rs. 496.1 mn in Q4 FY25 (Consolidated).
What is Bodal Chemicals Ltd share price analysis?
Bodal Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 35.1 with a market cap of ₹2,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Bodal Chemicals Ltd planning capital expenditure?
The presentation mentions a new greenfield expansion under the "Way Forward" section (Page 28), indicating plans for capacity ramp-up and ongoing internal efficiencies.
Keep Bodal Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
